Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK). (Q50198550)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 December 2017
edit
Language Label Description Also known as
English
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK).
scientific article published on 30 December 2017

    Statements

    title
    Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK) (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    29402752
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29402752%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    14 March 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q50198550&oldid=1739250212"